Work

An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia ( THETIS ): 5‐year results

Year: 2022

Type: article

Source: American Journal of Hematology

DOI: 10.1002/ajh.26592

Authors: Yong‐Rong Lai, Maria Domenica Cappellini, Yesim Aydinok, John Porter, Zeynep Karakas, Vip Viprakasit, Noppadol Siritanaratkul, Antonis Kattamis, Rongrong Liu, Miguel Izquierdo, Janet Lasher, Sameera Govindaraju, Ali Taher

Institutions: Guangxi Medical University, University of Milan, Ege University, Ege Üniversitesi Tıp Fakültesi Hastanesi, University College Hospital, Istanbul University, Siriraj Hospital, National and Kapodistrian University of Athens, Novartis (Switzerland), Novartis (India), American University of Beirut Medical Center

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis

OpenAlex ID: W4280532851

FWCI: 0.466

Cites: 6

Cited by: 5

Related to: 10